Medical device chemical characterization analysis is a systematic scientific process that identifies and quantifies extractable and leachable compounds from device materials, forming the foundation of biological risk assessment under ISO 10993-18. This testing approach enables manufacturers to demonstrate biocompatibility safety, support global regulatory submissions, and reduce reliance on traditional animal testing. This article provides a comprehensive technical overview of chemical characterization testing, including applicable standards, sample types, analytical methods, and practical applications.
Technical Overview
Chemical characterization is the process of qualitatively and quantitatively evaluating the chemical composition of medical device materials, as well as the compounds that may migrate out of those materials during patient contact. It has become a cornerstone of modern biocompatibility evaluation and is formally recognized in the ISO 10993 series of standards, particularly ISO 10993-18 (Chemical characterization of medical device materials within a risk management process) and ISO 10993-17 (Toxicological risk assessment of medical device constituents).
Regulatory authorities worldwide, including the FDA, European notified bodies operating under the EU MDR, and NMPA in China, increasingly expect chemical characterization data as part of biological evaluation files. Rather than relying solely on biological endpoint testing, a chemistry-based toxicological risk assessment allows manufacturers to demonstrate that patient exposure to leachable substances remains below safety thresholds. This approach supports the principle of the 3Rs (Replacement, Reduction, and Refinement) in animal testing and provides a scientifically defensible basis for biocompatibility claims.
The characterization workflow typically involves four stages: (1) material and formulation review, (2) extraction studies under simulated or exaggerated conditions, (3) analytical detection and identification of extractables, and (4) toxicological evaluation against health-based exposure limits. The entire process is embedded within the manufacturer's ISO 14971 risk management framework.
Testing Samples
Polymeric and Plastic Materials
Thermoplastics, thermosets, and polymer-based components such as catheters, syringes, infusion sets, housings, and tubing are among the most common subjects of chemical characterization. These materials may release monomers, oligomers, plasticizers, antioxidants, colorants, and processing additives during extraction studies.
Elastomers and Silicones
Rubber components, silicone seals, gaskets, and diaphragms used in drug delivery systems, stoppers, and pump assemblies are evaluated for vulcanization agents, curing by-products, siloxane oligomers, and peroxide decomposition products.
Metallic Materials
Stainless steels, titanium alloys, cobalt-chromium alloys, and nitinol used in implants, instruments, and orthopedic devices are assessed for elemental release, alloying elements, surface treatments, and passivation residues.
Ceramics and Composites
Bioceramics, glass, carbon fiber composites, and dental materials are characterized for ionic leachables, degradation products, and residual processing chemicals.
Coatings, Adhesives, and Surface Treatments
Hydrophilic coatings, antimicrobial layers, drug coatings, and bonding agents are studied for extractable profiles and migration behavior under clinical-use conditions.
Finished Devices and Packaging Systems
In addition to raw materials, complete devices and their primary packaging are tested as delivered, since manufacturing, sterilization (ethylene oxide, gamma, e-beam), and storage can generate additional leachable compounds such as sterilant residues and radiolysis degradation products.
Testing Items
Chemical characterization studies are designed around the device's nature of body contact (surface, external communicating, or implant) and contact duration (limited, prolonged, or long-term). Core testing items include:
- Extractables and leachables (E&L) profiling, including target, non-target, and unknown compound screening
- Volatile organic compounds (VOCs) such as residual solvents and monomers
- Semi-volatile organic compounds (SVOCs) including plasticizers, antioxidants, and lubricants
- Non-volatile residue (NVR) determination
- Elemental impurities and heavy metals, such as lead, cadmium, arsenic, mercury, chromium, and nickel
- Inorganic ions, including chloride, sulfate, nitrate, and ammonium
- Poly cyclic siloxanes and siloxane oligomers from silicone-based materials
- Degradation products from hydrolytic, oxidative, or enzymatic processes
- Physicochemical parameters such as pH, acidity/alkalinity, turbidity, evaporable residue, ultraviolet absorption, and total organic carbon (TOC)
- Extractable metals from metallic and metallized components
- Toxicological risk assessment outputs based on identified compounds and estimated patient doses
Testing Methods
Testing is performed in accredited third-party laboratories using validated chromatographic, spectroscopic, and elemental analytical techniques. Extraction studies are designed according to ISO 10993-12 and ISO 10993-18, using both polar (e.g., water, saline) and non-polar (e.g., hexane) solvents under simulated-use or exaggerated conditions to generate a worst-case extractables profile.
Organic Analytical Techniques
- Gas chromatography coupled with mass spectrometry (GC-MS) for volatile and semi-volatile organic compounds
- Headspace GC-MS (HS-GC-MS) for residual solvents and highly volatile substances
- Liquid chromatography coupled with mass spectrometry (LC-MS, LC-MS/MS) for non-volatile and thermally labile compounds
- High-performance liquid chromatography with UV/fluorescence detection (HPLC-UV/FLD) for targeted quantification
- Fourier-transform infrared spectroscopy (FTIR) for material identity confirmation and polymer fingerprinting
- Nuclear magnetic resonance spectroscopy (NMR) for structural elucidation of unknowns
Inorganic and Elemental Techniques
- Inductively coupled plasma mass spectrometry (ICP-MS) for trace elemental impurities
- Inductively coupled plasma optical emission spectrometry (ICP-OES) for major and minor elements
- Ion chromatography (IC) for inorganic anions and cations
- Atomic absorption spectroscopy (AAS) for targeted metal quantification
Data Evaluation and Thresholds
Identified and unidentified extractables are evaluated against the Analytical Evaluation Threshold (AET) as defined in ISO 10993-18, which is derived from the Toxicological Screening Limit and the product's clinical use context. Compounds reported above the AET are either identified for toxicological assessment or, if unidentified, conservatively evaluated using worst-case assumptions such as the TTC (Threshold of Toxicological Concern) approach described in ISO 21709 and ICH M7 concepts.
Applications
- Biocompatibility testing programs as a scientific substitute or supplement to certain in vivo biological tests, such as systemic toxicity and implantation studies, under a documented risk assessment
- Regulatory submissions including FDA 510(k), PMA, EU MDR technical documentation, NMPA registration in China, and submissions in Japan and Korea
- Material selection and design verification during research and development
- Equivalence assessment when changing materials, suppliers, manufacturing sites, or sterilization methods
- Supplier qualification and incoming material control for polymers, elastomers, and packaging components
- Extractables and leachables studies for drug-device combination products, prefilled syringes, inhalation and infusion delivery systems, in alignment with USP and ICH Q3E guidance
- Change control and post-market surveillance to support the continued safety of marketed devices
- Support for chemical characterization sections of biological evaluation reports (BER) required by notified bodies and regulators
FAQ
What is the difference between extractables and leachables?
Extractables are compounds released from device materials under exaggerated laboratory conditions such as elevated temperature and aggressive solvents. Leachables are compounds that actually migrate into patients under normal clinical use conditions. Extractables studies generate a worst-case compound library, while leachables studies, often performed via simulated-use extraction, reflect realistic patient exposure.
Can chemical characterization replace animal testing?
In many cases, yes. When a comprehensive chemical characterization demonstrates that all extractable compounds fall below toxicological safety thresholds, regulators may accept a chemistry-based risk assessment in place of certain biological endpoint tests. This approach is explicitly supported by ISO 10993-1 and encouraged by regulatory authorities committed to reducing animal use, though the decision must be justified within the biological evaluation plan.
What is the Analytical Evaluation Threshold (AET)?
The AET is a reporting threshold defined in ISO 10993-18 that determines which extractable compounds require identification and toxicological evaluation. It is calculated from the dose of the device extract delivered to the patient and an assumed toxicological screening limit, adjusted by an uncertainty factor to account for analytical variability.
Which standards govern chemical characterization?
The primary standards are ISO 10993-18 for chemical characterization, ISO 10993-17 for toxicological risk assessment, and ISO 10993-12 for sample preparation and reference materials. Supporting standards include ISO 10993-19 for physicochemical, morphological, and topographical characterization, ISO 10993-13 for polymer degradation, and ISO 10993-15 for metals and ceramics, along with USP general chapters and ICH Q3E guidance for combination products.
How long does a chemical characterization study take?
Typical timelines range from several weeks to several months depending on study complexity. Screening-level extractables profiling with standard GC-MS, LC-MS, and ICP-MS panels can often be completed within four to eight weeks, while full studies including compound identification, validated leachables quantification, and toxicological risk assessment may require twelve weeks or longer.
When should chemical characterization be performed?
Chemical characterization should be initiated early in product development to inform material selection, repeated during design verification, and updated whenever a material, supplier, manufacturing process, or sterilization method changes. It is also a core element of any biological evaluation report submitted for regulatory clearance or approval.
